Literature DB >> 29232011

Autograft immune effector cells and survival in autologous peripheral blood hematopoietic stem cell transplantation.

Luis F Porrata1.   

Abstract

In addition to stem cells, T-cells, natural killer cells, dendritic cells, and monocytes are also collected and infused from the autograft in patients undergoing autologous peripheral blood hematopoietic stem cell transplantation. Recent reports have shown that these autograft immune effector cells can affect the clinical outcome postautologous peripheral blood hematopoietic stem cell transplantation. In this article, I will review the clinical impact on the survival of these autograft immune effector cells conferring the concept of autologous graft versus tumor effect.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  autologous graft versus tumor effect; immunologic autograft engineering; survival

Mesh：

Year:  2017        PMID： 29232011     DOI： 10.1002/jca.21611

Source DB:  PubMed          Journal:  J Clin Apher        ISSN： 0733-2459            Impact factor:   2.821


  5 in total

1.  The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograft.

Authors:  Matthew J Rees; Peter Mollee; Jun Yen Ng; Alex Murton; Jose Filipe Gonsalves; Ashish Panigrahi; Hayley Beer; Joanna Loh; Philip Nguyen; Sam Hunt; Hayden Jina; Rebecca Wayte; Gaurav Sutrave; Jocelyn Tan; Chathuri Abeyakoon; Ashlyn Chee; Bradley Augustson; Akash Kalro; Cindy Lee; Shivam Agrawal; Leonid Churilov; Chong Chyn Chua; Andrew Boon Ming Lim; Daniela Zantomio; Andrew Grigg
Journal:  Bone Marrow Transplant       Date:  2021-04-28       Impact factor: 5.483

2.  The metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome.

Authors:  Benedikt Jacobs; Dimitrios Mougiakakos; Silja Richter; Martin Böttcher; Simon Völkl; Andreas Mackensen; Evelyn Ullrich
Journal:  Sci Rep       Date:  2022-07-06       Impact factor: 4.996

Review 3.  Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An Update.

Authors:  Yavuz M Bilgin
Journal:  J Blood Med       Date:  2021-06-02

4.  A Pilot Study of Circulating Monocyte Subsets in Patients Treated with Stem Cell Transplantation for High-Risk Hematological Malignancies.

Authors:  Ida Marie Rundgren; Elisabeth Ersvær; Aymen Bushra Ahmed; Anita Ryningen; Øystein Bruserud
Journal:  Medicina (Kaunas)       Date:  2020-01-18       Impact factor: 2.430

5.  Blood Graft and Outcome After Autologous Stem Cell Transplantation in Patients With Primary Central Nervous System Lymphoma.

Authors:  Anu Partanen; Outi Kuittinen; Antti Turunen; Jaakko Valtola; Marja Pyorala; Hanne Kuitunen; Kaija Vasala; Taru Kuittinen; Pentti Mantymaa; Jukka Pelkonen; Esa Jantunen; Ville Varmavuo
Journal:  J Hematol       Date:  2021-12-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.